Search

Your search keyword '"Kübler Kirsten"' showing total 134 results

Search Constraints

Start Over You searched for: Author "Kübler Kirsten" Remove constraint Author: "Kübler Kirsten"
134 results on '"Kübler Kirsten"'

Search Results

1. AHRR and SFRP2 in primary versus recurrent high-grade serous ovarian carcinoma and their prognostic implication

2. In vivo intratumor angiogenic treatment effects during taxane-based neoadjuvant chemotherapy of ovarian cancer

3. Diverse mutational landscapes in human lymphocytes

5. Supplementary Figures 8-9 from Targeted Activation of RNA Helicase Retinoic Acid–Inducible Gene-I Induces Proimmunogenic Apoptosis of Human Ovarian Cancer Cells

6. Supplementary Figures 2-3 from Targeted Activation of RNA Helicase Retinoic Acid–Inducible Gene-I Induces Proimmunogenic Apoptosis of Human Ovarian Cancer Cells

7. Supplementary Methods, Tables 1-4, Figure Legends 1-9 from Targeted Activation of RNA Helicase Retinoic Acid–Inducible Gene-I Induces Proimmunogenic Apoptosis of Human Ovarian Cancer Cells

8. Supplementary Figures 4-7 from Targeted Activation of RNA Helicase Retinoic Acid–Inducible Gene-I Induces Proimmunogenic Apoptosis of Human Ovarian Cancer Cells

9. Supplementary Figure 1 from Targeted Activation of RNA Helicase Retinoic Acid–Inducible Gene-I Induces Proimmunogenic Apoptosis of Human Ovarian Cancer Cells

12. A deep learning system accurately classifies primary and metastatic cancers using passenger mutation patterns

13. Combined burden and functional impact tests for cancer driver discovery using DriverPower

14. Integrative pathway enrichment analysis of multivariate omics data

15. Pathway and network analysis of more than 2500 whole cancer genomes

16. Divergent mutational processes distinguish hypoxic and normoxic tumours

17. Genomic footprints of activated telomere maintenance mechanisms in cancer

20. Sequence-specific activation of the DNA sensor cGAS by Y-form DNA structures as found in primary HIV-1 cDNA

23. COOBoostR: An Extreme Gradient Boosting-Based Tool for Robust Tissue or Cell-of-Origin Prediction of Tumors.

28. A deep learning system accurately classifies primary and metastatic cancers using passenger mutation patterns

33. The Mutational Landscapes of Cancers Serve as Records of Early Malignant Transformation

34. RNA sequence analysis reveals macroscopic somatic clonal expansion across normal tissues

35. Widespread Chromosomal Losses and Mitochondrial DNA Alterations as Genetic Drivers in Hürthle Cell Carcinoma

36. Tumoral PD-L1 expression defines a subgroup of poor-prognosis vulvar carcinomas with non-viral etiology

37. A mutational signature reveals alterations underlying deficient homologous recombination repair in breast cancer

38. Accumulation of ALDH1-positive cells after neoadjuvant chemotherapy predicts treatment resistance and prognosticates poor outcome in ovarian cancer

43. Immunogenic cell death of human ovarian cancer cells induced by cytosolic poly(I:C) leads to myeloid cell maturation and activates NK cells

44. Targeted Activation of RNA Helicase Retinoic Acid–Inducible Gene-I Induces Proimmunogenic Apoptosis of Human Ovarian Cancer Cells

48. Foxp3+ cell infiltration and granzyme B+/Foxp3+ cell ratio are associated with outcome in neoadjuvant chemotherapy-treated ovarian carcinoma.

50. Retrospective evaluation of whole exome and genome mutation calls in 746 cancer samples

Catalog

Books, media, physical & digital resources